Logo image of BPYPN

BROOKFIELD PROPERTY PART - BPY 5 3/4 PERP (BPYPN) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:BPYPN - BMG162491648

13.3999 USD
+0.13 (+0.95%)
Last: 12/10/2025, 4:30:02 PM
Fundamental Rating

2

Overall BPYPN gets a fundamental rating of 2 out of 10. We evaluated BPYPN against 82 industry peers in the Chemicals industry. BPYPN may be in some trouble as it scores bad on both profitability and health. BPYPN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

BPYPN had negative earnings in the past year.
BPYPN had a positive operating cash flow in the past year.
In the past 5 years BPYPN reported 4 times negative net income.
BPYPN had a positive operating cash flow in 4 of the past 5 years.
BPYPN Yearly Net Income VS EBIT VS OCF VS FCFBPYPN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5B -10B

1.2 Ratios

With a Return On Assets value of -0.35%, BPYPN perfoms like the industry average, outperforming 48.78% of the companies in the same industry.
BPYPN has a Return On Equity of -3.89%. This is comparable to the rest of the industry: BPYPN outperforms 42.68% of its industry peers.
The Return On Invested Capital of BPYPN (2.56%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for BPYPN is below the industry average of 6.05%.
Industry RankSector Rank
ROA -0.35%
ROE -3.89%
ROIC 2.56%
ROA(3y)-0.29%
ROA(5y)-0.3%
ROE(3y)-3.87%
ROE(5y)-3.15%
ROIC(3y)3.23%
ROIC(5y)3.15%
BPYPN Yearly ROA, ROE, ROICBPYPN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

1.3 Margins

Looking at the Operating Margin, with a value of 36.76%, BPYPN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Operating Margin of BPYPN has declined.
With an excellent Gross Margin value of 54.92%, BPYPN belongs to the best of the industry, outperforming 97.56% of the companies in the same industry.
BPYPN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 36.76%
PM (TTM) N/A
GM 54.92%
OM growth 3Y-4.33%
OM growth 5Y-3.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.18%
GM growth 5Y-4.52%
BPYPN Yearly Profit, Operating, Gross MarginsBPYPN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1

2. Health

2.1 Basic Checks

BPYPN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for BPYPN has been increased compared to 1 year ago.
The number of shares outstanding for BPYPN has been reduced compared to 5 years ago.
BPYPN has a better debt/assets ratio than last year.
BPYPN Yearly Shares OutstandingBPYPN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
BPYPN Yearly Total Debt VS Total AssetsBPYPN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

BPYPN has a Debt/Equity ratio of 3.96. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 3.96, BPYPN is doing worse than 86.59% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 3.96
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC0.47
WACC5.51%
BPYPN Yearly LT Debt VS Equity VS FCFBPYPN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B

2.3 Liquidity

BPYPN has a Current Ratio of 0.21. This is a bad value and indicates that BPYPN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.21, BPYPN is doing worse than 96.34% of the companies in the same industry.
BPYPN has a Quick Ratio of 0.21. This is a bad value and indicates that BPYPN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of BPYPN (0.20) is worse than 96.34% of its industry peers.
Industry RankSector Rank
Current Ratio 0.21
Quick Ratio 0.2
BPYPN Yearly Current Assets VS Current LiabilitesBPYPN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 45.99% over the past year.
Looking at the last year, BPYPN shows a very negative growth in Revenue. The Revenue has decreased by -25.68% in the last year.
BPYPN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.12% yearly.
EPS 1Y (TTM)45.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.2%
Revenue 1Y (TTM)-25.68%
Revenue growth 3Y8.67%
Revenue growth 5Y2.12%
Sales Q2Q%-29.03%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BPYPN Yearly Revenue VS EstimatesBPYPN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B
BPYPN Yearly EPS VS EstimatesBPYPN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 0 1 -1 2 -2

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BPYPN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BPYPN Price Earnings VS Forward Price EarningsBPYPN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BPYPN is valued a bit more expensive than 68.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.71
BPYPN Per share dataBPYPN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 500 -500 1K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 11.09%, BPYPN is a good candidate for dividend investing.
BPYPN's Dividend Yield is rather good when compared to the industry average which is at 3.98. BPYPN pays more dividend than 96.34% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.31, BPYPN pays a better dividend.
Industry RankSector Rank
Dividend Yield 11.09%

5.2 History

The dividend of BPYPN has a limited annual growth rate of 1.63%.
BPYPN has been paying a dividend for over 5 years, so it has already some track record.
BPYPN has decreased its dividend in the last 3 years.
Dividend Growth(5Y)1.63%
Div Incr Years0
Div Non Decr Years2
BPYPN Yearly Dividends per shareBPYPN Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

BPYPN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-140.86%
EPS Next 2YN/A
EPS Next 3YN/A
BPYPN Yearly Income VS Free CF VS DividendBPYPN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5B -10B

BROOKFIELD PROPERTY PART - BPY 5 3/4 PERP

NASDAQ:BPYPN (12/10/2025, 4:30:02 PM)

13.3999

+0.13 (+0.95%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners16.66%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap98.62M
Revenue(TTM)7.20B
Net Income(TTM)-350.00M
Analysts46.67
Price TargetN/A
Short Float %0.15%
Short Ratio0.68
Dividend
Industry RankSector Rank
Dividend Yield 11.09%
Yearly Dividend1.48
Dividend Growth(5Y)1.63%
DP-140.86%
Div Incr Years0
Div Non Decr Years2
Ex-Date12-01 2025-12-01 (0.359375)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF 0.17
P/B 0.01
P/tB 0.01
EV/EBITDA 16.71
EPS(TTM)-0.92
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-820.79
FCFYN/A
OCF(TTM)79.48
OCFY593.17%
SpS978.67
BVpS1221.74
TBVpS914.4
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.35%
ROE -3.89%
ROCE 3.25%
ROIC 2.56%
ROICexc 2.62%
ROICexgc 2.7%
OM 36.76%
PM (TTM) N/A
GM 54.92%
FCFM N/A
ROA(3y)-0.29%
ROA(5y)-0.3%
ROE(3y)-3.87%
ROE(5y)-3.15%
ROIC(3y)3.23%
ROIC(5y)3.15%
ROICexc(3y)3.36%
ROICexc(5y)3.27%
ROICexgc(3y)3.45%
ROICexgc(5y)3.36%
ROCE(3y)4.09%
ROCE(5y)3.99%
ROICexgc growth 3Y-3.47%
ROICexgc growth 5Y2.52%
ROICexc growth 3Y-3.3%
ROICexc growth 5Y2.51%
OM growth 3Y-4.33%
OM growth 5Y-3.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.18%
GM growth 5Y-4.52%
F-Score3
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 3.96
Debt/FCF N/A
Debt/EBITDA 12.24
Cap/Depr 2509.85%
Cap/Sales 91.99%
Interest Coverage 0.87
Cash Conversion 20.09%
Profit Quality N/A
Current Ratio 0.21
Quick Ratio 0.2
Altman-Z N/A
F-Score3
WACC5.51%
ROIC/WACC0.47
Cap/Depr(3y)1344.37%
Cap/Depr(5y)1108.74%
Cap/Sales(3y)60.6%
Cap/Sales(5y)50.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.2%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-25.68%
Revenue growth 3Y8.67%
Revenue growth 5Y2.12%
Sales Q2Q%-29.03%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-26.01%
EBIT growth 3Y3.96%
EBIT growth 5Y-1.64%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-9.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y171.87%
OCF growth 3Y17.7%
OCF growth 5Y9.63%

BROOKFIELD PROPERTY PART - BPY 5 3/4 PERP / BPYPN FAQ

What is the ChartMill fundamental rating of BROOKFIELD PROPERTY PART - BPY 5 3/4 PERP (BPYPN) stock?

ChartMill assigns a fundamental rating of 2 / 10 to BPYPN.


Can you provide the valuation status for BROOKFIELD PROPERTY PART - BPY 5 3/4 PERP?

ChartMill assigns a valuation rating of 0 / 10 to BROOKFIELD PROPERTY PART - BPY 5 3/4 PERP (BPYPN). This can be considered as Overvalued.


Can you provide the profitability details for BROOKFIELD PROPERTY PART - BPY 5 3/4 PERP?

BROOKFIELD PROPERTY PART - BPY 5 3/4 PERP (BPYPN) has a profitability rating of 3 / 10.


Can you provide the financial health for BPYPN stock?

The financial health rating of BROOKFIELD PROPERTY PART - BPY 5 3/4 PERP (BPYPN) is 1 / 10.